1 year return (CAGR)
380.33%
Damora Therapeutics, Inc. Exchange (NASDAQ, USD)
DMRA
20.27
-0.17 (-0.83%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
10.87%
5 year return (CAGR)
-28.10%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.25B
Price/Sales
-
Ent value
738.44M
Price/Book
2.42
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
30.68%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 20.38 |
| Daily high | 20.73 |
| Daily low | 19.39 |
| Daily Volume | 875K |
| All-time high | 421.00 |
| 1y analyst estimate | 44.67 |
| Beta | 1.48 |
| EPS (TTM) | -4.30 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| DMRA | S&P500 | |
| Current price drop from All-time high | -95.19% | -1.38% |
| Highest price drop | -99.47% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -86.21% | -10.68% |
| Avg time to new high | 148 days | 12 days |
| Max time to new high | 1465 days | 1805 days |
News
